These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 3670536
1. [Clinical effects of lipo-prostaglandin E1 in patients with delayed cerebral vasospasm]. Korosue K, Izawa I, Hamano S, Ishida K, Kurihara E, Nagao T, Tamaki N, Matsumoto S. No Shinkei Geka; 1987 Jun; 15(6):635-40. PubMed ID: 3670536 [Abstract] [Full Text] [Related]
2. [Lipo prostaglandin E1 administration in the acute stage following subarachnoid hemorrhage]. Korosue K, Kondoh T, Ishikawa A, Suzuki H, Nagao T, Tamaki N, Matsumoto S. No Shinkei Geka; 1988 Jun; 16(5 Suppl):509-15. PubMed ID: 3399005 [Abstract] [Full Text] [Related]
6. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality. Akahori H, Takamura T, Hayakawa T, Ando H, Yamashita H, Kobayashi K. Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001 [Abstract] [Full Text] [Related]
7. Progress in the prostaglandin E1-therapy of the intermittent claudication by means of bolus injections of LIPO-prostaglandin E1 (LIPO-PGE1). Scheffler P, Gross J, Markwirth T, Maier J, Schieffer H. Eur J Clin Pharmacol; 1996 Jun; 51(3-4):235-9. PubMed ID: 9010691 [Abstract] [Full Text] [Related]
9. Prostaglandin E1 incorporated in lipid microspheres (lipo PGE1). Otomo S, Mizushima Y, Aihara H, Yokoyama K, Watanabe M, Yanagawa A. Drugs Exp Clin Res; 1985 Dec; 11(9):627-31. PubMed ID: 3880049 [Abstract] [Full Text] [Related]
10. The effect of prostaglandin E1 on local cerebral blood flow during cerebral-aneurysm clip ligation. Abe K, Fujino Y, Demizu A, Takauchi Y, Hoshida T, Kamada K, Mashimo T, Yoshiya I. Eur J Anaesthesiol; 1991 Sep; 8(5):359-63. PubMed ID: 1935924 [Abstract] [Full Text] [Related]
11. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy. Hoshi K, Mizushima Y, Kiyokawa S, Yanagawa A. Drugs Exp Clin Res; 1986 Sep; 12(8):681-5. PubMed ID: 3757764 [Abstract] [Full Text] [Related]
12. A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders. Mizushima Y, Shiokawa Y, Homma M, Kashiwazaki S, Ichikawa Y, Hashimoto H, Sakuma A. J Rheumatol; 1987 Feb; 14(1):97-101. PubMed ID: 3553591 [Abstract] [Full Text] [Related]
20. A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats. Goto J, Araki H, Otomo S, Aihara H. Drugs Exp Clin Res; 1986 Feb; 12(11):917-21. PubMed ID: 3816509 [Abstract] [Full Text] [Related] Page: [Next] [New Search]